All In Biotech

Drug Trial Radar · NCT03466073

A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP

A Double-blind, Placebo-controlled, Dose-escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Plasma Gelsolin Added to Standard of Care in Subjects Hospitalized for Acute Community-acquired Pneumonia

Last checked: Nov 20, 2026Latest source record: Jan 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

33

Actual

Start

Aug 28, 2018

Primary completion

Apr 2, 2019

Study completion Apr 2, 2019

Sponsor

Lead sponsor
BioAegis Therapeutics Inc.Industry
Sponsor type
Industry
First posted
Mar 15, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 1b/2a, Double-blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Plasma gelsolin (rhu-pGSN) Added to Standard of Care in Subjects Hospitalized for Acute Community-acquired Pneumonia (CAP)

Conditions

  • Community-acquired Pneumonia

Interventions

  • Recombinant Human Plasma GelsolinDrug

    Recombinant human plasma gelsolin lyophilized for reconstitution, reconstituted in sterile water

  • Normal Saline PlaceboOther

    Normal saline in volume equivalent to drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: 0-28 days

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • Cairns Hospital

    Cairns, Queensland, Australia

  • Box Hill Hospital

    Box Hill, Victoria, Australia

  • Footscray Hospital

    Footscray, Victoria, Australia

  • LTD Geo Hospitals, Mtskheta Multiprofile Medical Center

    Mtskheta, Georgia

  • JSC Rustavi Central Hospital

    Rustavi, Georgia

  • LTD Central University Clinic After Academic N. Kipshidze

    Tbilisi, Georgia

  • LTD S. Khechinashvili University Hospital

    Tbilisi, Georgia

  • LTD 5th Clinical Hospital

    Tbilisi, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.